Prescription treatment with zytiga abiraterone acetate. Zaltrap is a recombinant fusion protein consisting of vascular endothelial growth factor vegfbinding portions from the extracellular domains of human vegf receptor 1 and 2 fused to the fc portion of the human igg 1. Medscape metastatic colon cancer dosing for zaltrap zivaflibercept. Discontinue zaltrap therapy in patients who develop fistula see dosage and administration 2. Zaltrap must not be administered as an intravitreal injection see sections 4. Restricted access do not disseminate or copy without approval.
Zaltrap is used in combination with irinotecan or folfiri as therapy for patients with. With the vial sitting on a flat surface, insert the tip of the syringe into the adapter. Some patients may need every 4 week 52019 dosage and administration 2 82019 indications and usage eylea is a vascular endothelial growth factor vegf inhibitor indicated for. Before prescribing keytruda, please read the selected safety information on pages 8 to 10 and the accompanying prescribing information.
Name of the medicinal product zaltrap 25 mgml concentrate for solution for infusion 2. Zaltrap is to be administered only as an intravenous infusion over 1 hour. Treatment for metastatic colorectal cancer mcrc zaltrap. Zetia has not been studied in fredrickson type i, iii, iv, and v dyslipidemias. Highlights of prescribing information these highlights do not include all the information needed to use blincyto safely and effectively. Sanofi assumes all zaltrap development from regeneron. Refer to prescribing information for irinotecan, fluorouracil, and leucovorin for the recommended dosage and dosage modifications for these drugs.
Highlights of prescribing information diabetic macular edema. There is no clinical trial experience administering zaltrap to patients with nyha class iii or iv heart failure. Initial approval criteria coverage is provided in the following conditions. Persons with disabilities having problems accessing the pdf files below may call 301 7963634 for assistance. This medicinal product is subject to additional monitoring. Eylea aflibercept injection, for intravitreal use initial u. Zaltrap zivaflibercept rationale for inclusion in pa program. Ixempra as monotherapy is indicated for the treatment of metastatic or locally. A new option for the treatment of patients with metastatic. Zaltrap zivaflibercept zaltrap zivaflibercept is a prescription anticancer medicine used in combination with the chemotherapy regimen 5fluorouracil, leucovorin, and irinotecanfolfiri to treat metastatic colorectal cancer that has progressed during or after treatment with other anticancer medicines that include oxaliplatin. Highlights of prescribing information these highlights do not include all the information needed to use taltz safely and effectively. Zaltrap reference guide for safe and effective use from the american society of.
Zaltrap zivaflibercept is a prescription anticancer medicine used in combination with the chemotherapy regimen 5fluorouracil, leucovorin, and irinotecanfolfiri to treat metastatic colorectal cancer that has progressed during or after treatment with other anticancer medicines that include oxaliplatin. Dacarbazine for injection is a colorless to an ivory colored solid which is light sensitive. Each vial contains 200 mg of dacarbazine the active ingredient, citric acid monohydrate and mannitol. This solution is readytouse and may be administered directly to the patient without further preparation. Annals of pharmacotherapy zivaflibercept zaltrap for the. To prepare reduced doses for patients with baseline crcl less than or equal to 60 mlmin, withdraw the. Zaltrap zivaflibercept metastatic colorectal cancer. April 20 vol 6 no 3 payers guide to new fda approvals select drug profiles, payers guide lynne lederman, phd, medical writer download pdf. Pdf icon download leaflet view the patient leaflet in pdf format. See full prescribing information for complete boxed warning. Apply 1 inch of ointment intraanally every 12 hours for up to 3 weeks a finger covering such as plastic wrap, a disposable surgical glove or finger cot should be placed on the finger to apply the ointment.
Zelboraf is not indicated for treatment of patients with wildtype braf melanoma. Highlights of prescribing information adequately rehydrate. The patient information leaflet pil is the leaflet included in the pack with a medicine. Pharmacology angiogenesis, the formation and differentiation of the vasculature, plays a key role in the growth of many solid tumors and has been a target of drug development for agents to treat mcrc, among other solid tumors. In agreement with npra, the product registration holder of zaltrap has issued a direct healthcare professional communication dhpc letter on this matter.
Zaltrap is indicated for use in combination with 5fluorouracil, leucovorin, and irinotecan folfiri in patients with metastatic colorectal cancer mcrc that is resistant to or has progressed following an oxaliplatincontaining regimen. Healthcare professionals are asked to report any suspected adverse reactions. Highlights of prescribing information for intravenous. Colorectal cancer with unresectable metachronous metastases and previous adjuvant folfox. Highlights of prescribing information for psoriatic. Patient continues to meet the criteria identified in section iii. Zaltrap increases the risk of grade 34 hypertension. Dacarbazine for injection is reconstituted and administered intravenously ph 34.
Dec 01, 2019 zaltrap, in combination with fluorouracil, leucovorin, irinotecanfolfiri, is indicated for the treatment of patients with metastatic colorectal cancer mcrc that is resistant to or has progressed following an oxaliplatincontaining regimen. This will allow quick identification of new safety information. Dosage and administration for rectiv nitroglycerin ointment. Zaltrapfolfiri treatment delay or dose modification. Renewal criteria coverage can be renewed based upon the following criteria. Zaltrap 25 mgml concentration for solution for infusion. Zaltrap zivaflibercept solution, concentrate dailymed. Zaltrap is indicated for use in combination with 5fluorouracil, leucovorin, irinotecan folfiri in patients with metastatic colorectal cancer mcrc that is resistant to or has progressed following an oxaliplatincontaining regimen. Zaltrap zivaflibercept injection for intravenous infusion.
Zaltrap, a vascular endothelial growth factor inhibitor, in combination with fluorouracil, leucovorin, irinotecan folfiri, is indicated for the treatment of patients with metastatic colorectal cancer that is resistant to or has progressed following an oxaliplatincontaining regimen. Zaltrap dose to 2 mg per kg see warnings and precautions 5. The effect of zetia on cardiovascular morbidity and mortality has not been determined. Posology the recommended dose of zaltrap, administered as an intravenous infusion over 1 hour, is 4 mg kg of body weight, followed by the folfiri regimen. Regeneron will no longer be required to reimburse sanofi for 50% of the development expenses pertaining to zaltrap per the original agreement. Zaltrap, in combination with 5fluorouracil, leucovorin, irinotecan folfiri, is indicated for patients with metastatic colorectal cancer mcrc that is. Single use vials for the treatment of a single eye.
Do not use vial if the solution is discolored or cloudy or if the solution contains particles. Nexavar tablets are round, biconvex, red filmcoated tablets, debossed with the bayer cross on one side and 200 on the other side. Compendial uses zaltrap is used in combination with irinotecan or folfiri as therapy for patients with. Highlights of prescribing information these highlights do not include all the information needed to use zaltrap safely and effectively. Find information on zydelig idelalisib and how you may be able to help your patients with therapy. See full prescribing information, including boxed warning. Ixempra, a microtubule inhibitor, in combination with capecitabine is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline and a taxane 1. Zaltrap should be administered under the supervision of a physician experienced in the use of antineoplastic medicinal products. Zaltrap zivaflibercept prior auth criteria proprietary information. Zaltrap is a recombinant fusion protein consisting of vascular endothelial growth. Do not reenter the vial after the initial puncture. Follow applicable special handling and disposal procedures. Zaltrap, in combination with 5fluorouracil, leucovorin, irinotecanfolfiri, is indicated for patients with metastatic colorectal cancer mcrc that is resistant to or has progressed following an oxaliplatincontaining regimen. Zytiga abiraterone acetate is a prescription medicine that is used along with prednisone.
Zaltrap zivaflibercept last updated 92019 moda health. There are no data on presence of drug in human milk, or effects on breastfed infant or. Do not remove the vial adapter from the package or touch the inside of the package of the adapter. Vectibix panitumumab is for treating patients with wildtype ras metastatic colorectal cancer cancer that has spread outside of the colon and rectum. Highlights of prescribing information these highlights do not. Dacarbazine is an anticancer agent designated chemically. Vision impaired people having problems accessing certain pages of a pdf file may call 301 7963634 for assistance. Eylea is an fdaapproved, antivegf medication thats administered by an injection into the eye to treat wet amd, dme, mefrvo, and dr. Due to hyperosmolality mosmolkg of the zaltrap concentrate, undiluted zaltrap concentrate must not be administered as an intravenous push or bolus. Zaltrap zivaflibercept injection, for intravenous use.
Zaltrap can only be obtained with a prescription and treatment should be supervised by a doctor who is experienced in using cancer medicines. Zaltrap is a clear, colorless to pale yellow solution. Tablets containing sorafenib tosylate 274 mg equivalent to 200 mg of sorafenib. Zytiga is used to treat men with prostate cancer that has spread to other parts of the body. Zaltrap 25mgml concentrate for solution for infusion patient. Highlights of prescribing information wounds have adequately. Highlights of prescribing information these highlights do. Xeloda tablets should be swallowed whole with water within 30 minutes after a meal. Jevtana is a prescription medicine used with the steroid medicine prednisone to treat men with prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has worsened after treatment with other medicines, including docetaxel. The most common laboratory abnormalities incidence. Administer zaltrap prior to any component of the folfiri regimen on the day of treatment.
648 621 510 300 987 1166 289 1315 1143 1238 274 1010 351 174 1404 1388 553 531 767 1009 1385 283 110 333 969 403 454 868 227 430 379 1476 1138 96 1357